NCT02961608View on ClinicalTrials.gov

Conversion Pharmacodynamic Study in Stable Renal Transplant Patients Receiving Tacrolimus Two Times a Day to a New Formulation of Tacrolimus - LCP Tacro - 1 Time a Day.

PHASE4CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

May 31, 2016

Primary Completion Date

September 30, 2018

Study Completion Date

September 30, 2018

Conditions
Kidney Transplant; Complications
Interventions
DRUG

Drug conversion from Tacrolimus (Prograf® or Adoport®) to LCP-Tacrolimus (Envarsus®)

Drug conversion from Tacrolimus (Prograf® or Adoport®) to LCP-Tacrolimus (Envarsus®)

Trial Locations (1)

08028

Nephrology Department- Hospital Universitari Bellvtge, L'Hospitalet de Llobregat

All Listed Sponsors
lead

Hospital Universitari de Bellvitge

OTHER

NCT02961608 - Conversion Pharmacodynamic Study in Stable Renal Transplant Patients Receiving Tacrolimus Two Times a Day to a New Formulation of Tacrolimus - LCP Tacro - 1 Time a Day. | Biotech Hunter | Biotech Hunter